ArticleScientific reports2022
A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Integration of Developed Mathematical Model for Predicting and Monitoring the Spread of Epidemics and Pandemics: The Case of COVID-19 in Rwanda.Public health challenges · 2026Article
- Expanding modeling boundaries to design more resilient vaccine supply networks.Health care management science · 2025Article
- Studying Disease Reinfection Rates, Vaccine Efficacy, and the Timing of Vaccine Rollout in the Context of Infectious Diseases: A COVID-19 Case Study.International journal of environmental research and public health · 2025Article
- Article
- Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns.Infectious diseases and therapy · 2024Article
- Susceptible-Infected-Susceptible type COVID-19 spread with collective effects.Scientific reports · 2023Article
- Pharmaceutical and non-pharmaceutical interventions for controlling the COVID-19 pandemic.Royal Society open science · 2023Article
- Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia.Nature communications · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccines for COVID-19 have allowed countries to combat the spread of the disease. However, new variants have resulted in significant spikes in cases and raised severe health and economic concerns. We present a COVID-19 model to predict coupled effects of vaccine multiple-dose roll-out strategies, vaccine efficacy, waning immunity, population level of caution, sense of safety, under-reporting of cases, and highly prevalent variants such as the Delta (B.1.617.2) and Omicron (B.1.1.529). The modeling framework can incorporate new variants as they emerge to give critical insights into the new cases and guide public policy decision-making concerning vaccine roll-outs and reopening strategies. The model is shown to recreate the history of COVID-19 for five countries (Germany, India, Japan, South Africa, and the United States). Parameters for crucial aspects of the pandemic, such as population behavior, new variants, vaccination, and waning immunity, can be adjusted to predict pandemic scenarios. The model was used to conduct trend analysis to simulate pandemic dynamics taking into account the societal level of caution, societal sense of safety, and the proportions of individuals vaccinated with first, second, and booster doses. We used the results of serological testing studies to estimate the actual number of cases across countries. The model allows quantification of otherwise hard to quantify aspects such as the infectious power of variants and the effectiveness of government mandates and population behavior. Some example cases are presented by investigating the competitive nature of COVID variants and the effect of different vaccine distribution strategies between immunity groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.